ALKERMES | Ativos

Assets Alterar Data
AbbVie USD 136.22B 854M 2023-09
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Malin Corporation EUR 101.8M 186.1M 2023-06
Merck USD 106.73B 2.26B 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Otsuka Holdings JPY 3.42T 109.2B 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



ALKERMES Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.